Stockreport

Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio

Annovis Bio, Inc.  (ANVS) 
PDF Buntanetap improved cognition in pTau217-positive early AD patientsThe drug reduced neurotoxic proteins as well as biomarkers of neuroinflammation and neurodegenerationB [Read more]